Whole-genome conditional two-locus analysis identifies novel candidate genes for late-onset Parkinson's disease

Neurogenetics

Volumn 10, Issue 3, 2009, Pages 173-181

  Gonzalez Perez A ^a   Gayan J ^a   Marin J ^b   Galan J J ^a   Saez M E ^a   Real, L M ^a   Antunez C ^b,c   Ruiz, A ^a  

^a NeoCodex ^*  (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

^c Fundación Alzheimur   (Spain)

Author keywords

Genetic epistasis; Interaction; Parkinson's disease; Single nucleotide polymorphism; Whole genome association study

Indexed keywords

DJ 1 PROTEIN; LEUCINE RICH REPEAT KINASE 2; PARKIN; PROTEIN; PROTEIN MAPT; PROTEIN PINK; PROTEIN SNCA; PROTEIN UCHL1; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; GENE LOCUS; GENETIC ASSOCIATION; GENETIC RISK; GENOME ANALYSIS; HUMAN; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; ONSET AGE; PARKINSON DISEASE; PRIORITY JOURNAL; GENETIC DATABASE; GENETIC EPISTASIS; GENETIC MARKER; GENETIC PREDISPOSITION; GENETICS; GENOME; MIDDLE AGED; MOLECULAR GENETICS; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGE OF ONSET; AGED; AGED, 80 AND OVER; DATABASES, GENETIC; EPISTASIS, GENETIC; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENOME; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PARKINSON DISEASE; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 70249126212     PISSN: 13646745     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10048-009-0170-8     Document Type: Article

References (43)

1. SM Williams, et al. 2007 Problems with genome-wide association studies Science 316 5833 1840 1842 17605173
2. MH Polymeropoulos, et al. 1996 Mapping of a gene for Parkinson's disease to chromosome 4q21-q23 Science 274 5290 1197 1199 8895469 10.1126/science.274. 5290.1197 1:CAS:528:DyaK28XmvVyit74%3D (Pubitemid 26389286)
3. EK Tan LM Skipper 2007 Pathogenic mutations in Parkinson disease Hum Mutat 28 7 641 653 17385668 10.1002/humu.20507 1:CAS:528:DC%2BD2sXosFyqtLY%3D (Pubitemid 47047290)
4. MJ Farrer 2006 Genetics of Parkinson disease: paradigm shifts and future prospects Nat Rev Genet 7 4 306 318 16543934 10.1038/nrg1831 1:CAS:528:DC%2BD28XisFWgtLk%3D
5. DM Maraganore, et al. 2005 High-resolution whole-genome association study of Parkinson disease Am J Hum Genet 77 5 685 693 16252231 10.1086/496902 1:CAS:528:DC%2BD2MXhtFyhtL%2FF (Pubitemid 41513273)
6. M Bialecka, et al. 2006 Polymorphism in semaphorin 5A (Sema5A) gene is not a marker of Parkinson's disease risk Neurosci Lett 399 1-2 121 123 16481103 10.1016/j.neulet.2006.01.038 1:CAS:528:DC%2BD28XjvFShurk%3D
7. J Clarimon, et al. 2006 Conflicting results regarding the semaphorin gene (SEMA5A) and the risk for Parkinson disease Am J Hum Genet 78 6 1082 1084 16685660 10.1086/504727 1:CAS:528:DC%2BD28XltVyksLw%3D (Pubitemid 43787701)
8. A Elbaz, et al. 2006 Lack of replication of thirteen single-nucleotide polymorphisms implicated in Parkinson's disease: a large-scale international study Lancet Neurol 5 11 917 923 17052658 10.1016/S1474-4422(06)70579-8 1:CAS:528:DC%2BD28Xht1eiurnI (Pubitemid 44574406)
9. HC Fung, et al. 2006 Genome-wide genotyping in Parkinson's disease and neurologically normal controls: first stage analysis and public release of data Lancet Neurol 5 11 911 916 17052657 10.1016/S1474-4422(06)70578-6 1:CAS:528:DC%2BD28Xht1eiurnP (Pubitemid 44556544)
10. J Gayán, et al. 2008 A method for detecting epistasis in genome-wide studies using case-control multi-locus association analysis BMC Genomics 9 360 18667089 10.1186/1471-2164-9-360
11. Wang K, Li M, Bucan M (2007) Pathway-based approaches for analysis of genomewide association studies. Am J Hum Genet 81(6). doi: 10.1086/522374 (Pubitemid 350211456)
12. Y Zhang JS Liu 2007 Bayesian inference of epistatic interactions in case-control studies Nat Genet 39 9 1167 1173 17721534 10.1038/ng2110 1:CAS:528:DC%2BD2sXps12gtbs%3D (Pubitemid 47340656)
13. Pattin KA et al (2008) A computationally efficient hypothesis testing method for epistasis analysis using multifactor dimensionality reduction. Genet Epidemiol (in press)
14. M Hutton, et al. 1998 Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17 Nature 393 6686 702 705 9641683 10.1038/31508 1:CAS:528:DyaK1cXktVyqsr0%3D (Pubitemid 28289662)
15. W Li J Reich 2000 A complete enumeration and classification of two-locus disease models Hum Hered 50 6 334 349 10899752 10.1159/000022939 1:STN:280:DC%2BD3cvlvVWqsg%3D%3D
16. DW Hosmer S Lemeshow 1992 Confidence interval estimation of interaction Epidemiology 3 5 452 456 1391139 10.1097/00001648-199209000-00012 1:STN:280:DyaK3s%2FgtlKhug%3D%3D
17. Q Yang, et al. 1999 Case-only design to measure gene-gene interaction Epidemiology 10 2 167 170 10069253 10.1097/00001648-199903000-00014 1:STN:280:DyaK1M7ms1OrsQ%3D%3D
18. J Hoh J Ott 2003 Mathematical multi-locus approaches to localizing complex human trait genes Nat Rev Genet 4 9 701 709 12951571 10.1038/nrg1155 1:CAS:528:DC%2BD3sXmvVWlsrY%3D (Pubitemid 37046137)
19. I Ionita M Man 2006 Optimal two-stage strategy for detecting interacting genes in complex diseases BMC Genet 7 39 16776843
20. DM Evans, et al. 2006 Two-stage two-locus models in genome-wide association PLoS Genet 2 9 e157 17002500 10.1371/journal.pgen.0020157 (Pubitemid 44504794)
21. A Julia, et al. 2008 Genome-wide association study of rheumatoid arthritis in the Spanish population: KLF12 as a risk locus for rheumatoid arthritis susceptibility Arthritis Rheum 58 8 2275 2286 18668548 10.1002/art.23623
22. M Farrer, et al. 2001 alpha-Synuclein gene haplotypes are associated with Parkinson's disease Hum Mol Genet 10 17 1847 1851 11532993 10.1093/hmg/10.17. 1847 1:CAS:528:DC%2BD3MXntFCitbs%3D
23. GD Mellick DM Maraganore PA Silburn 2005 Australian data and meta-analysis lend support for alpha-synuclein (NACP-Rep1) as a risk factor for Parkinson's disease Neurosci Lett 375 2 112 116 15670652 10.1016/j.neulet.2004. 10.078 1:CAS:528:DC%2BD2MXmvF2htg%3D%3D
24. R Peng, et al. 2003 Mutation screening and association analysis of the parkin gene in Parkinson's disease patients from South-West China Eur Neurol 49 2 85 89 12584415 10.1159/000068505 1:CAS:528:DC%2BD3sXitFais78%3D (Pubitemid 36206651)
25. J Satoh Y Kuroda 1999 Association of codon 167 Ser/Asn heterozygosity in the parkin gene with sporadic Parkinson's disease Neuroreport 10 13 2735 2739 10511432 10.1097/00001756-199909090-00008 1:CAS:528:DyaK1MXmsFOnurc%3D
26. L Skipper, et al. 2005 Comprehensive evaluation of common genetic variation within LRRK2 reveals evidence for association with sporadic Parkinson's disease Hum Mol Genet 14 23 3549 3556 16269443 10.1093/hmg/ddi376 1:CAS:528:DC%2BD2MXht1Ggsr3F (Pubitemid 41754656)
27. EK Tan, et al. 2004 alpha-Synuclein haplotypes implicated in risk of Parkinson's disease Neurology 62 1 128 131 14718715 1:STN:280: DC%2BD2c%2FitFGmsg%3D%3D
28. AB West, et al. 2002 Functional association of the parkin gene promoter with idiopathic Parkinson's disease Hum Mol Genet 11 22 2787 2792 12374768 10.1093/hmg/11.22.2787 1:CAS:528:DC%2BD38XotVSjsLo%3D
29. C Paisan-Ruiz, et al. 2008 Comprehensive analysis of LRRK2 in publicly available Parkinson's disease cases and neurologically normal controls Hum Mutat 29 4 485 490 18213618 10.1002/humu.20668 1:CAS:528:DC%2BD1cXlslWls7o%3D
30. S Biskup, et al. 2005 Common variants of LRRK2 are not associated with sporadic Parkinson's disease Ann Neurol 58 6 905 908 16254973 10.1002/ana.20664 1:CAS:528:DC%2BD2MXhtlaks7jM (Pubitemid 41746880)
31. C Paisan-Ruiz, et al. 2006 Testing association between LRRK2 and Parkinson's disease and investigating linkage disequilibrium J Med Genet 43 2 e9 16467219 10.1136/jmg.2005.036889 1:STN:280:DC%2BD28%2FotFWkug%3D%3D
32. N Dupre, et al. 2007 LRRK2 is not a significant cause of Parkinson's disease in French-Canadians Can J Neurol Sci 34 3 333 335 17803032
33. CJ Hu, et al. 2000 Polymorphisms of the parkin gene in sporadic Parkinson's disease among Chinese in Taiwan Eur Neurol 44 2 90 93 10965160 10.1159/000008203 1:CAS:528:DC%2BD3cXmslSntr4%3D
34. Y Izumi, et al. 2001 Genetic studies in Parkinson's disease with an alpha-synuclein/NACP gene polymorphism in Japan Neurosci Lett 300 2 125 127 11207390 10.1016/S0304-3940(01)01557-9 1:CAS:528:DC%2BD3MXht1OrsLc%3D (Pubitemid 32162940)
35. C Klein, et al. 2000 Association studies of Parkinson's disease and parkin polymorphisms Ann Neurol 48 1 126 127 10894229 10.1002/1531-8249(200007) 48:1<126::AID-ANA22>3.0.CO;2-K 1:STN:280:DC%2BD3czltVOhtQ%3D%3D
36. C Paisan-Ruiz, et al. 2005 LRRK2 gene in Parkinson disease: mutation analysis and case control association study Neurology 65 5 696 700 16157901 10.1212/01.WNL.0000167552.79769.b3 1:CAS:528:DC%2BD2MXovVOhsrw%3D (Pubitemid 41285847)
37. A Parsian, et al. 1998 Mutation, sequence analysis, and association studies of alpha-synuclein in Parkinson's disease Neurology 51 6 1757 1759 9855543 1:CAS:528:DyaK1MXhsVOlsA%3D%3D
38. P Pastor, et al. 2001 Analysis of the coding and the 5′ flanking regions of the alpha-synuclein gene in patients with Parkinson's disease Mov Disord 16 6 1115 1119 11748744 10.1002/mds.1198 1:STN:280:DC%2BD3MnpvFChsQ%3D%3D (Pubitemid 36041225)
39. DG Healy, et al. 2006 UCHL-1 is not a Parkinson's disease susceptibility gene Ann Neurol 59 4 627 633 16450370 10.1002/ana.20757 1:CAS:528: DC%2BD28XktFWjsrg%3D
40. E Leroy, et al. 1998 The ubiquitin pathway in Parkinson's disease Nature 395 6701 451 452 9774100 10.1038/26652 1:CAS:528:DyaK1cXms1antLo%3D (Pubitemid 28462431)
41. C Dong, et al. 2007 Gene-centric characteristics of genome-wide association studies PLoS One 2 12 e1262 18060058 10.1371/journal.pone.0001262 (Pubitemid 351722487)
42. JP Ioannidis 2008 Why most discovered true associations are inflated Epidemiology 19 5 640 648 18633328 10.1097/EDE.0b013e31818131e7
43. PD Sasieni 1997 From genotypes to genes: doubling the sample size Biometrics 53 1253 1261 9423247 10.2307/2533494 1:STN:280:DyaK1c%2FosFagsw%3D%3D (Pubitemid 28013569)